logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
X

Xiangjiao Meng

Shandong Cancer Hospital and Institute

32H指数
165论文数
4.1K被引数
收录论文 79
发表时间
logo
Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study局限性小细胞肺癌中省略临床靶区的有效性与安全性：一项大规模多中心真实世界研究
errRadiotherapy and Oncology
IF5.3
err2026-09-19
err0
PREAI
errXiaolong Wang; Xinrui Yu; Xiaoli Liu; Kaikai Zhao; Yankang Li; Hong Feng; Meili Sun; Jinming Yu; Yu Chen; Xiangjiao Meng
err分享
err收藏
Prophylactic cranial irradiation versus active MRI surveillance for limited-stage small-cell lung cancer achieving response after chemoradiotherapy: a protocol for a randomized, controlled, multicenter, phase III trial预防性脑照射与主动MRI监测用于化疗放疗后达到缓解的局限期小细胞肺癌的随机对照多中心III期试验方案
errRespiratory Research
IF5
err2026-09-08
err0
errOAAI
errZhonghui Wei; Yu Chen; Jinming Yu; Xiangjiao Meng
err分享
err收藏
Arginine Methyltransferase PRMT3 Suppresses Tumor-intrinsic Immunity via Promoting cGAS Methylation精氨酸甲基转移酶PRMT3通过促进cGAS甲基化抑制肿瘤内源性免疫
errCancer Letters
IF10.1
err2026-08-25
err0
PREAI
errYu Chen; Yang Liu; Jianfeng Peng; Xiaolong Wang; Zhonghui Wei; Xiaoyan Yin; Xueying Zhai; Yankang Li; Jinming Yu; Xiangjiao Meng
err分享
err收藏
Pregnancy promotes tumor metastasis through adenosine-induced immunosuppressive neutrophils in pre-metastatic microenvironment妊娠通过腺苷诱导的免疫抑制性中性粒细胞促进肿瘤转移前微环境中的肿瘤转移
errNature Communications
IF15.7
err2026-08-04
err0
errOAAI
errChen Chen; Jiahong Shi; Yutiantian Lei; Qian Wang; Peihai Cao; Dairu Hou; Mengdi Huang; Ruiying Wang; Qiuyu Mu; Tingting Lv; Rui Jia; Mingjun Si; Dingge Jiang; Lei Li; Zhixuan Cai; Yakun Huang; Jiahao Sun; Lianying Jiao; Zhengtao Xiao; Yuhan Li; Binxian Wang; Shan Huang; Wenqian Du; Lu Bai; Jinlu Ma; Suxia Han; Baojun Zhang; Chen Lin; Hui Guo; Xiangjiao Meng; Yuzhu Hou
err分享
err收藏
Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancer可切除和潜在可切除III期非小细胞肺癌患者的免疫治疗机遇与挑战
errCancer Biology & Medicine
IF8.4
err2026-06-15
err0
PREAI
errCui, Yuzhen; Xu, Jingdong; Wen, Junxu; Peng, Jianfeng; Ren, Jiangao; Liu, Ailing; Meng, Xiangjiao; Huang, Zhaoqin; Liu, Anwen
err分享
err收藏
Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study对限局期小细胞肺癌患者采用诱导免疫化疗后行根治性放射治疗的疗效：一项多中心研究
errCancer Biology & Medicine
IF8.4
err2026-01-01
err0
PREAI
errWen, Junxu; Wang, Qian; Yu, Xinrui; Liu, Yang; Yin, Xiaoyan; Li, Shanshan; Zhao, Heng; Huang, Zhaoqin; Chen, Yu; Meng, Xiangjiao
err分享
err收藏
Garsorasib in Patients with KRAS G12C-Mutated Non-Small-Cell Lung Cancer: A Pooled Analysis of Phase 1/2 StudyGarsorasib 在 KRAS G12C 突变非小细胞肺癌患者中的研究：一项 I/II 期研究合并分析
errEuropean Journal of Cancer
IF7.1
err2025-11-29
err0
PREAI
errZhengbo Song; Ziming Li; Yiping Zhang; Pingli Wang; Liyan Jiang; Yanqiu Zhao; Jianying Zhou; Xicheng Wang; Wu Zhuang; Jianhua Shi; Dingzhi Huang; Xiaomin Dang; Shundong Cang; Yi Gong; Shi Jin; Weiwei Li; Xiaorong Dong; Junping Zhang; Mingfang Zhao; Xiangjiao Meng
err分享
err收藏
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trialIvonescimab 联合化疗与 tislelizumab 联合化疗作为晚期鳞状非小细胞肺癌的一线治疗（HARMONi-6）：一项随机、双盲、Ⅲ期临床试验
errThe Lancet
IF97.3
err2025-10-19
err0
PREAI
errZhiwei Chen; Fang Yang; Zhou Jiang; Longhua Sun; Lin Wu; Zhengxiang Han; Yun Fan; Yanqiu Zhao; Xingya Li; Haipeng Xu; Xiangjiao Meng; Ying Liu; Zhiye Zhang; Hui Luo; Xuelei Ma; Xuezhen Ma; Qin Shi; Zhongmin Zhang; Runxiang Yang; Pingli Wang; Pinhua Pan; Xiaohong Ai; Jie Li; Xingxiang Pu; Zhiwu Wang; Jian Fang; Ming He; Yong He; Shuliang Guo; Juan Li; Hongbiao Wang; Junqiang Zhang; Qian Chu; Xuewen Liu; Shenpeng Ying; Hongcheng Wu; Hongmei Sun; Yinghua Ji; Ming Zhou; Chao Cao; Kejing Tang; Zhengguo Li; Dairong Li; Zhihong Zhang; Jie Li; Jianya Zhou; Hongzhong Yang; Yingying Du; Hui Yang; Jian Shi; Hualin Chen; Wenting Li; Dongmei Lu; Mingxiu Hu; Zhongmin Maxwell Wang; Baiyong Li; Michelle Xia; Shun Lu
err分享
err收藏
COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1+CD8+T cell infiltration in NSCLC
errCANCER BIOLOGY & MEDICINE
IF8.4
err2025-10-01
err0
errOAAI
errMa, Lin; Bai, Menglin; Wang, Yao; Zhai, Xueying; Yu, Jinming; Meng, Xiangjiao
err分享
err收藏
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-10-01
err8
PREAI
errFang, Wenfeng; Wu, Lin; Meng, Xiangjiao; Yao, Yu; Zuo, Wei; Yao, Wenxiu; Xie, Yanyan; Zhang, Yu; Cui, Jiuwei; Zhang, Yongchang; Li, Xingya; Zhuang, Wu; Fang, Jian; Wang, Qiming; Jiang, Wei; Li, Kai; Bai, Yuju; Luo, Yongzhong; Ma, Fang; Yu, Yan; Zheng, Wei; Liu, Zhentian; Yang, Bin; Ma, Rui; Fang, Yong; Yang, Runxiang; Jiang, Liyan; Hu, Jie; Yang, Jiacheng; Diao, Yina; Jin, Xiaoping; Ge, Junyou; Yang, Yunpeng; Zhang, Li
err分享
err收藏
Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-naïve Chinese patients with KRASG12C-mutated metastatic colorectal cancer: a pooled analysis from phase I part of two studiesIBI351 (fulzerasib) 单药治疗未使用KRASG12C抑制剂的中国KRASG12C-mutated转移性结直肠癌患者的疗效和安全性: 两项研究的I期汇总分析
errSignal Transduction and Targeted Therapy
IF52.7
err2025-07-25
err0
errOAAI
errYing Yuan; Yanhong Deng; Yongdong Jin; Zengqing Guo; Yueyin Pan; Cunji Wang; Zhiwu Wang; Yi Hu; Dong Hua; Xiangjiao Meng; Zhiye Zhang; Mingfang Zhao; Xiaorong Dong; Dingzhi Huang; Xiaoyan Li; Lian Liu; Meili Sun; Huijuan Wang; Xiuwen Wang; Nong Yang; Mingjun Zhang; Sheng Hu; Dongde Wu; Jingjing Huang; Sujie Zhang; Mengna Huang; Kefeng Ding
err分享
err收藏
Additions and subtractions of radiotherapy in patients with oligometastatic non-small cell lung cancer under the era of immunotherapy免疫治疗时代寡转移性非小细胞肺癌患者的放疗增减策略
errcritical reviews in oncology hematology
IF0
err2025-07-11
err0
errOAAI
errZiran Sun; Junxu Wen; Wenxing Cui; Minghao Yu; Yankang Li; Xiangjiao Meng
err分享
err收藏
Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer双特异性抗体在非小细胞肺癌治疗中的应用及未来前景
errCANCER BIOLOGY & MEDICINE
IF8.4
err2025-04-07
err0
errOAAI
errWen, Junxu; Cui, Wenxing; Yin, Xiaoyan; Chen, Yu; Liu, Ailing; Wang, Qian; Meng, Xiangjiao
err分享
err收藏
Myocarditis prediction in locally advanced or metastatic lung cancer patients with cardiac parameters abnormalities undergoing immunotherapy: development and validation of a risk assessment model
errBMC CANCER
IF3.4
err2025-03-25
err0
errOAAI
errLi, Shanshan; Du, Feng; Zhang, Yan; Wang, Qiang; Dou, Jianjian; Meng, Xiangjiao
err分享
err收藏
A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial靶向B7H3抗体药物偶联物在晚期实体瘤中的研究：一项1/1b期临床试验
errNATURE MEDICINE
IF50
err2025-03-13
err0
errOAAI
errMa, Yuxiang; Yang, Yunpeng; Huang, Yan; Fang, Wenfeng; Xue, Jinhui; Meng, Xiangjiao; Fu, Siqing; Zheng, Yulong; Liu, Jian; Liu, Zhihua; Zhuang, Wu; Rosen, Seth; Qu, Song; Li, Bihui; Li, Mingjun; Zhao, Yanqiu; Yang, Shujun; Ji, Yinghua; Sommerhalder, David; Luo, Suxia; Yang, Kunyu; Li, Jingao; Lv, Dongqing; Zhang, Peng; Zhao, Yuanyuan; Hong, Shaodong; Zhang, Yang; Zhao, Shen; Chin, Steve; Zhang, Xian; Lian, Wei; Cai, Jiaqiang; Xue, Tongtong
err分享
err收藏
Case Report: Grade 4 pneumonitis occurred after thoracic radiotherapy and dacomitinib in a patient with lung adenocarcinoma
errFRONTIERS IN ONCOLOGY
IF3.3
err2025-02-25
err0
errOAAI
errLiu, Ailing; Wen, Junxu; Zhao, Kaikai; Jiang, Liyang; Meng, Xiangjiao
err分享
err收藏
Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study晚期实体瘤患者中KRAS G12C IBI351的有效共价不可逆抑制剂: 首次人体I期研究
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-11-01
err0
PREAI
errZhou, Qing; Yang, Nong; Zhao, Mingfang; Huang, Dingzhi; Zhao, Jun; Yu, Yan; Yuan, Ying; Sun, Longhua; Dong, Xiaorong; Zhang, Tongmei; Chu, Qian; Li, Xingya; Meng, Xiangjiao; Wang, Huijuan; Wang, Xiang; Wu, Dongde; Hu, Sheng; Shan, Jinlu; Liu, Lian; Sun, Meili; Zhang, Zhiye; Zhu, Haibo; Huang, Jingjing; Huang, Mengna; Cheng, Lingge; Zhang, Sujie; Zhou, Hui; Wu, Yi-Long
err分享
err收藏
TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2024-10-01
err0
errOAAI
errDong, Baiqiang; Chen, Long; Pang, Qingsong; Jiang, Ou; Ge, Hong; Cheng, Yufeng; Zhou, Rongrong; Meng, Xiangjiao; Li, Jie; Zhu, Xuan; Wang, Xunqiang; Cao, Qiuyue; Ji, Yongling; Chen, Ming
err分享
err收藏
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial信迪利单抗联合安罗替尼和化疗作为广泛期小细胞肺癌的二线或后续治疗：一项Ⅱ期临床试验
errSignal Transduction and Targeted Therapy
IF52.7
err2024-09-16
err35
errOAAI
errHan, Xiao; Guo, Jun; Li, Lingyu; Huang, Yong; Meng, Xue; Wang, Linlin; Zhu, Hui; Meng, Xiangjiao; Shao, Qian; Li, Xing; Zhang, Yan; Wang, Jin; Chen, Yanhua; Zhang, Yingjie; Chen, Yiru; Zhu, Changbin; Wang, Zhehai
err分享
err收藏
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as fi rst-line therapy for extensive-stage small-cell - cell lung cancer (ES-SCLC): a phase II trial
errECLINICALMEDICINE
IF10
err2024-09-01
err3
PREAI
errChen, Dawei; Zou, Bing; Li, Butuo; Gao, Aiqin; Huang, Wei; Shao, Qian; Meng, Xiangjiao; Zhang, Pinliang; Tang, Xiaoyong; Hu, Xudong; Zhang, Yan; Guo, Jun; Zhao, Changhong; Yuan, Jiajia; Li, Qian; Zhu, Changbin; Yu, Jinming; Wang, Linlin
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
陈
陈郁 (Yu Chen)
H 指数: 138 · 论文数: 1.6K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
R
Ralph R. Weichselbaum
H 指数: 124 · 论文数: 1.3K
M
Matthias Mack
H 指数: 101 · 论文数: 419
李
李姗姗 (Shanshan Li)
H 指数: 99 · 论文数: 1.2K
查看更多